Skip to main content
. Author manuscript; available in PMC: 2021 Jun 14.
Published in final edited form as: Mod Pathol. 2020 Dec 14;34(5):934–941. doi: 10.1038/s41379-020-00723-4

Table 1.

Clinicopathologic features of EH characterized by GATA6-FOXO1 fusions

EH# Age/
Sex
Site/Size/
Procedure/FU
Microscopic Features IHC positive
1 42/F R leg, subcutis 1 cm Resection, negative margins Biphasic, vasoformation and solid growth
Intravascular
Abundant inflammation (lympho-plasma cells),
Extravasated red blood cells
1 MF/10 HPF, mild atypia
CD31, CD34, ERG
2 32/M Cheek, skin 1.2 cm; Resection, negative margins; NED 6 months Biphasic, vasoformation and solid growth
Scant to no inflammation
Limited extravasation
2 MF/10 HPFs, mild atypia
CD31, ERG
3 33/F Dura 3 x 2.5 x 1 cm aggregate; Craniotomy, intralesional resection; NED 36 months Biphasic, vasoformation and solid growth
Epithelioid, ovoid to spindling (short fascicles)
Abundant extravasated blood
Scant acute inflammation
2 MF/10 HPFs, moderate atypia
CD31, CD34
4 42/F H&N, nasopharyngeal 2.4 cm Biopsy only AWD 48 months Scant vasoformation
Epithelioid, solid, nodular
Scant to no inflammation
Moderate extravasated blood,
1 MF/10 HPFs, mild atypia
CD31, ERG
5 15/M Left upper back, Skin 0.5 x 0.3 cm Incomplete resection Biphasic, vasoformation and solid growth
Moderate extravasated blood
Scattered eosinophils
2 MF/10 HPF, moderate nuclear atypia
CD31, ERG

FU, follow-up; NED, no evidence of disease; AWD, alive with disease.